Transmucosal Delivery of Oxytocin to Rabbits Using a Mucoadhesive Buccal Patch

References

• Harris D., Robinson J. R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992; 81: 1–10
   PubMed Web of Science ®Google Scholar
• Dowty M. E., Knuth K. E., Irons B. K., Robinson J. R. Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm. Res. 1992; 9: 1113–1122
   PubMed Web of Science ®Google Scholar
• Anders R., Merkle H. P., Schurr W., Ziegler R. Buccal absorption of protirelin: an effective way to stimulate thyrotropin and prolactin. J. Pharm. Sci. 1983; 72: 1481–1483
   PubMed Web of Science ®Google Scholar
• Schurr W., Knoll B., Ziegler R., Anders R., Merkle H. P. Comparative study of intravenous, nasal, oral, and buccal TRH administration among healthy subjects. J. Endocrinol. Invest. 1985; 8: 41–44
   PubMed Web of Science ®Google Scholar
• Ho N. F. H., Barsuhn C. L. Buccal delivery of drugs. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1989; 16: 24
   Google Scholar
• Dowty M. E., Irons B. K., Knuth K. E., Robinson J. R. Characterization of transport pathways of thyrotropin releasing hormone in rabbit buccal mucosa. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1990; 17, Abstract D342
   Google Scholar
• Li C., Koch R. L., Raul V. A., Bhatt P. P., Johnston T. P. Absorption of thyrotropin releasing hormone in rats using a mucoadhesive buccal patch. Drug Dev. Indust. Pharm. 1997; 23: 245–252
   Web of Science ®Google Scholar
• Nakada Y., Awata N., Nakamichi C., Sugimoto I. The effect of additives on the oral mucosal absorption of human calcitonin. J. Pharmacobio. Dyn. 1988; 11: 394–401
   Google Scholar
• Heiber S. J., Ebert C. D., Dave S. C., Smith K., Kim S. W., Mix D. In vivo buccal delivery of calcitonin. J. Cont. Rel. 1994; 28: 269–270
   Web of Science ®Google Scholar
• Hoogstraate A. J., Verhoef J. C., Pijpers A., van Leengoed L. A. M. G., Verheijden J. H. M., Junginger H. E., Bodde H. E. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm. Res. 1996; 13: 1233–1237
   PubMed Web of Science ®Google Scholar
• Warren S. J., Kellaway I. W., Timmins P. Mucoadhesive hydrogels for buccal delivery of peptides. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1989; 16: 402–403
   Google Scholar
• Warren S. J., Kellaway I. W., Timmins P. The in vitro characterization of mucoadhesive hydrogel materials for the buccal delivery of peptides. J. Pharm. Pharmacol. 1990; 42: 140P
   PubMedGoogle Scholar
• Wolany G. J. M., Munzer J., Rummelt A., Merkle H. P. Buccal absorption of Sandostatin (octreotide) in conscious beagle dogs. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1990; 17, Abstract D341
   Google Scholar
• Li C., Bhatt P. P., Johnston T. P. In vitro release and permeation of oxytocin from a mucoadhesive buccal patch. Pharm. Devel. Technol. 1996; 1: 357–364
   PubMedGoogle Scholar
• Graves C. R. Agents that cause contraction or relaxation of the uterus. The Pharmacological Basis of Therapeutics, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, A. Goodman Gilman. McGraw-Hill, New York 1996; 942–945
   Google Scholar
• Chaudhury R. R., Walker J. M. The fate of injected oxytocin in the rabbit. J. Endocrin. 1959; 19: 189–192
   PubMed Web of Science ®Google Scholar
• Mueller-Heubach E., Morris M., Rose J. C. Fetal oxytocin and its extended forms at term with and without labor. Am. J. Obstet. Gynecol. 1995; 173: 375–381
   PubMed Web of Science ®Google Scholar
• Morris M., Stevens S. W., Adams M. R. Plasma oxytocin during pregnancy and lactation in the cynomolgus monkey. Biol. Reprod. 1980; 23: 782–787
   PubMed Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics, J. Swarbrick. Marcel Dekker, New York 1982; 1–42; 445–449
   Google Scholar
• Cassidy J. P., Landzert N. M., Quadros E. Controlled buccal delivery of buprenorphine. J. Com. Rel. 1993; 25: 21–29
   Web of Science ®Google Scholar
• Hoogstraate A. J., Verhoef J. C., Tuk B., Pijpers A., van Leengoed L. A. M. G., Verheijden J. H. M., Junginger H. E., Bodde H. E. In vivo buccal delivery of fluorescein isothiocyanate-dextran 440 with gtycoxy-cholate as an absorption enhancer in pigs. J. Pharm. Sci. 1996; 85: 457–460
   PubMed Web of Science ®Google Scholar
• Snedecor G. W., Cochran W. G. Statistical Methods, G. W. Snedecor, W. G. Cochran. Iowa State University Press, Ames 1980; 144–147
   Google Scholar
• Brazeau P. Drugs affecting uterine motility. The Pharmacological Basis of Therapeutics, L. S. Goodman, A. Gilman. Macmillan, New York 1975; 867–880
   Google Scholar
• Ho N. F. H., Barsuhn C. L., Burton P. S., Merkie H. P. Mechanistic insights to buccal delivery of proteinaceous substances. Adv. Drug Del. Rev. 1992; 8: 197–235
   Web of Science ®Google Scholar
• Veillard M. M., Longer M. A., Martens T. W., Robinson J. R. Preliminary study of oral mucosal delivery of peptide drugs. J. Cont. Rel. 1987; 6: 123–131
   Google Scholar
• Bergsjo P., Jenssen H. Nasal and buccal oxytocin for the induction of labor: a clinical trial. J. Obstet. Gynecol. Brit. Cwlth. 1969; 76: 131–136
   PubMedGoogle Scholar
• Wertz P. W., Hoogstraate A. J., Squier C. A. Biochemical basis of the permeability barrier in skin and oral mucosa. Oral Mucosal Drug Delivery, M. J. Rathbone. Marcel Dekker, New York 1996; 27–50
   Google Scholar
• Dillon T. F., Douglas R. G., du Vigneaud V., Barber M. L. Transbuccal administration of pitocin for induction and stimulation of labor. Obstet. Gynecol. 1960; 15: 587–592
   PubMed Web of Science ®Google Scholar